Loading...
Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia
Therapies targeting reductive/oxidative (redox) metabolism hold potential in cancers resistant to chemotherapy and radiation. A redox imaging marker would help identify cancers susceptible to redox-directed therapies. Copper(II)-diacetyl-bis(4-methylthiosemicarbazonato) (Cu-ATSM) is a PET tracer dev...
Na minha lista:
| Udgivet i: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Society of Nuclear Medicine
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7067520/ https://ncbi.nlm.nih.gov/pubmed/31586008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.230805 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|